AI Analysis
Log in to generate an AI summary for this stock.
Log in to generate a MOAT report for this stock.
Log in to generate an earnings report for this stock.
Log in to generate an operating leverage report for this stock.
Log in to generate a management report for this stock.
Log in to generate a valuation report for this stock.
ContextLogic Inc.
Video analysis: LOGC
All videosNo video analysis for this stock yet. Request one from our team.
News: LOGC
ContextLogic Holdings Inc. Publishes Q&A Following Second Quarter 2026 Results
OAKLAND, Calif., Aug. 21, 2026 (GLOBE NEWSWIRE) -- ContextLogic Holdings Inc. (OTCQB: LOGC) (“ContextLogic,” the “Company,” “we” or “our”) today published a Q&A document to its website following the release of its second quarter 2026 financial results.
ContextLogic Holdings Inc. Reports Second-Quarter 2026 Financial Results
OAKLAND, Calif., Aug. 13, 2026 (GLOBE NEWSWIRE) -- ContextLogic Holdings Inc. (OTCQB: LOGC) ("ContextLogic," the "Company," "we" or "our") today reported its financial results for the quarter and six months ended June 30, 2026.
ContextLogic Holdings Inc. (LOGC) M&A Call Prepared Remarks Transcript
ContextLogic Holdings Inc. (LOGC) M&A Call Prepared Remarks Transcript
ContextLogic Holdings Enters into Definitive Agreement to Acquire gChem from EagleTree Capital
COVINGTON, La.--(BUSINESS WIRE)--Gaylord Chemical Company, L.L.C. (“gChem”), a global leader in non-toxic ingredients used in high-growth applications, today announced that ContextLogic Holdings Inc. (OTCQB: “LOGC”) and its subsidiaries (“ContextLogic”) have entered into a definitive agreement to acquire gChem from investment funds managed by EagleTree Capital (“EagleTree”) and their co-investors (the “Transaction”).
ContextLogic to Acquire gChem for $850 Million
gChem will become ContextLogic's second operating business, following the acquisition of US Salt in February 2026 gChem is a sixty-four-year-old, vertically-integrated specialty chemicals company whose products serve highly specialized niches across diverse end markets, with decades-long customer relationships built on tailored, high-quality solutions ContextLogic shareholders will have the opportunity to commit additional capital in the Transaction via a rights offering, which has been fully backstopped at $9 per unit Transaction is expected to be materially accretive to free cash flow per unit OAKLAND, Calif., Aug. 05, 2026 (GLOBE NEWSWIRE) -- ContextLogic Holdings Inc. (OTCQB: LOGC) ("ContextLogic") today announced that ContextLogic Holdings, LLC and its newly formed subsidiary GCH Buyer, Inc. have entered into a definitive agreement to acquire the holding company of Gaylord Chemical, L.L.C.
LogicBio Therapeutics (LOGC) to Release Quarterly Earnings on Thursday
LogicBio Therapeutics (OTCMKTS:LOGC - Get Free Report) is anticipated to post its Q2 2026 resultson Thursday, August 6th. Analysts expect LogicBio Therapeutics to post earnings of ($0.0414) per share and revenue of $22.4760 million for the quarter. Interested persons may review the information on the company's upcoming Q2 2026 earning results page for the latest
ContextLogic Appoints Seth Siegel as Senior Advisor
OAKLAND, Calif., July 13, 2026 (GLOBE NEWSWIRE) -- ContextLogic Holdings Inc. (OTCQB: LOGC) (“ContextLogic,” the “Company,” “we” or “our”), a business ownership platform focused on acquiring and building a portfolio of high-quality, long-duration businesses, today announced that it has appointed Seth Siegel as a Senior Advisor.
Similar companies
-
Baozun Inc.
BZUN
·
NASDAQ
Compare
-
1-800-FLOWERS.COM, Inc.
FLWS
·
NASDAQ
Compare
-
ChargePoint Holdings, Inc.
CHPT
·
New York Stock Exchange
Compare
-
Studio City International Holdings Limited
MSC
·
New York Stock Exchange
Compare
-
Designer Brands Inc.
DBI
·
New York Stock Exchange
Compare
-
Aptera Motors Corp.
SEV
·
NASDAQ
Compare